Related references
Note: Only part of the references are listed.150th Anniversary Series: Desmosomes and the Hallmarks of Cancer
Otmar Huber et al.
CELL COMMUNICATION AND ADHESION (2015)
Novel Role for -Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1)
Marybeth Sechler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Tissue invasion and metastasis: Molecular, biological and clinical perspectives
W. G. Jiang et al.
SEMINARS IN CANCER BIOLOGY (2015)
Intensity of Follow-Up After Melanoma Surgery
Christopher P. Scally et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Dermcidin expression is associated with disease progression and survival among breast cancer patients
Heather Ann Brauer et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Seriniquinone, a selective anticancer agent, induces cell death by autophagocytosis, targeting the cancer-protective protein dermcidin
Lynnie Trzoss et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Human Antimicrobial Peptides and Proteins
Guangshun Wang
PHARMACEUTICALS (2014)
Why Do Cancer Cells Produce Serum Amyloid A Acute-Phase Protein?
S. A. Moshkovskii
BIOCHEMISTRY-MOSCOW (2012)
The Multiple Facets of Dermcidin in Cell Survival and Host Defense
Birgit Schittek
JOURNAL OF INNATE IMMUNITY (2012)
Vitronectin Increases Vascular Permeability by Promoting VE-Cadherin Internalization at Cell Junctions
Rong Li et al.
PLOS ONE (2012)
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo
Ingunn Holen et al.
BREAST CANCER RESEARCH (2012)
Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models
J. S. Vermaat et al.
ANNALS OF ONCOLOGY (2010)
Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Dummer et al.
ANNALS OF ONCOLOGY (2010)
Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target
Eleonore Froehlich
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis
Yi Wang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Simple Method for Quantitative Analysis of N-Linked Glycoproteins in Hepatocellular Carcinoma Specimens
Hyoung-Joo Lee et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Sialylated Lewis x Antigen Bearing Glycoproteins in Human Plasma
Wonryeon Cho et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Serum Level of Clusterin and Its Density in Men with Prostate Cancer as Novel Biomarkers Reflecting Disease Extension
Hideaki Miyake et al.
UROLOGY (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Serum Amyloid A As a Prognostic Marker in Melanoma Identified by Proteomic Profiling
Peter Findeisen et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients
Brandon L. Pierce et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The multiplex bead array approach to identifying serum biomarkers associated with breast cancer
Byoung Kwon Kim et al.
BREAST CANCER RESEARCH (2009)
Molecular interactions of acute phase serum amyloid A: Possible involvement in carcinogenesis
M. A. Vlasova et al.
BIOCHEMISTRY-MOSCOW (2006)
Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma
L Ben-Porat et al.
CANCER (2006)
Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer
B Shannan et al.
CELL DEATH AND DIFFERENTIATION (2006)
VEMS 3.0: Algorithms and computational tools for tandem mass spectrometry based identification of post-translational modifications in proteins
R Matthiesen et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas
AP Smith et al.
CANCER BIOLOGY & THERAPY (2005)
Clusterin regulates drug-resistance in melanoma cells
C Hoeller et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
PROSPECTIVE STUDY OF THE LEVELS OF SERUM CYTOKINES IN PATIENTS WITH MELANOMA: PROGNOSTIC VALUE
Jorge A. Martinez-Escribano et al.
ACTAS DERMO-SIFILIOGRAFICAS (2005)
Modulation of different clusterin isoforms in human colon tumorigenesis
S Pucci et al.
ONCOGENE (2004)
Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma
MD Boyano et al.
BRITISH JOURNAL OF CANCER (2000)
Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states
S Urieli-Shoval et al.
CURRENT OPINION IN HEMATOLOGY (2000)
Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor
SJ Wigmore et al.
BRITISH JOURNAL OF SURGERY (2000)
Share Paper
